QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
NYSE:AORT

Artivion (AORT) Stock Forecast, Price & News

$15.45
+0.50 (+3.34%)
(As of 06/6/2023 ET)
Compare
Today's Range
$14.88
$15.46
50-Day Range
$12.39
$15.45
52-Week Range
$9.64
$23.43
Volume
170,415 shs
Average Volume
142,300 shs
Market Capitalization
$631.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.50

Artivion MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
45.6% Upside
$22.50 Price Target
Short Interest
Bearish
7.89% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.11) to $0.19 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.62 out of 5 stars

Medical Sector

633rd out of 981 stocks

Surgical & Medical Instruments Industry

61st out of 97 stocks


AORT stock logo

About Artivion (NYSE:AORT) Stock

Artivion, Inc. engages in the research and development of solutions which address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. Its products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.

Receive AORT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Artivion and its competitors with MarketBeat's FREE daily newsletter.

AORT Stock News Headlines

Analyzing Artivion (NYSE:AORT) and PAVmed (NASDAQ:PAVM)
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Artivion: Q1 Earnings Insights
Artivion (AORT) Scheduled to Post Earnings on Thursday
Artivion Stock (NYSE:AORT), Dividends
Massive Insider Trade At Artivion
Why Artivion Stock Popped Today
Artivion: Q4 Earnings Snapshot
See More Headlines

AORT Price History

AORT Company Calendar

Last Earnings
2/17/2022
Today
6/06/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Employees
1,300
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$22.50
High Stock Price Forecast
$28.00
Low Stock Price Forecast
$14.00
Forecasted Upside/Downside
+47.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$-19,190,000.00
Pretax Margin
-6.71%

Debt

Sales & Book Value

Annual Sales
$313.79 million
Cash Flow
$0.61 per share
Book Value
$7.05 per share

Miscellaneous

Free Float
38,177,000
Market Cap
$624.24 million
Optionable
Optionable
Beta
1.39

Key Executives

  • James Patrick Mackin
    Chairman, President & Chief Executive Officer
  • David Ashley Lee
    Chief Financial & Operating Officer, EVP
  • Scott B. Capps
    Vice President-Clinical Research
  • Franz Peter Barthold
    Vice President-Research & Development
  • Marshall S. Stanton
    Chief Medical Officer & SVP-Clinical Research













AORT Stock - Frequently Asked Questions

Should I buy or sell Artivion stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Artivion in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AORT shares.
View AORT analyst ratings
or view top-rated stocks.

What is Artivion's stock price forecast for 2023?

4 brokers have issued twelve-month price objectives for Artivion's stock. Their AORT share price forecasts range from $14.00 to $28.00. On average, they expect the company's stock price to reach $22.50 in the next twelve months. This suggests a possible upside of 47.3% from the stock's current price.
View analysts price targets for AORT
or view top-rated stocks among Wall Street analysts.

How have AORT shares performed in 2023?

Artivion's stock was trading at $12.12 at the beginning of 2023. Since then, AORT stock has increased by 26.0% and is now trading at $15.27.
View the best growth stocks for 2023 here
.

When is Artivion's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our AORT earnings forecast
.

How were Artivion's earnings last quarter?

Artivion, Inc. (NYSE:AORT) posted its quarterly earnings results on Thursday, February, 17th. The company reported ($0.51) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by $0.45. The company had revenue of $79.39 million for the quarter, compared to the consensus estimate of $78 million. Artivion had a negative net margin of 9.17% and a positive trailing twelve-month return on equity of 0.65%.

What ETFs hold Artivion's stock?
What guidance has Artivion issued on next quarter's earnings?

Artivion issued an update on its FY 2023 earnings guidance on Thursday, May, 4th. The company provided EPS guidance of for the period. The company issued revenue guidance of $337.00 million-$348.00 million, compared to the consensus revenue estimate of $337.66 million.

What is Artivion's stock symbol?

Artivion trades on the New York Stock Exchange (NYSE) under the ticker symbol "AORT."

Who are Artivion's major shareholders?

Artivion's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (17.23%), Macquarie Group Ltd. (6.68%), Macquarie Group Ltd. (6.68%), Wellington Management Group LLP (5.86%), State Street Corp (3.94%) and Dimensional Fund Advisors LP (3.33%). Insiders that own company stock include Amy Horton, Andrew M Green, David Ashley Lee, Dennis B Maier, James P Mackin and Rochelle L Maney.
View institutional ownership trends
.

How do I buy shares of Artivion?

Shares of AORT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Artivion's stock price today?

One share of AORT stock can currently be purchased for approximately $15.27.

How much money does Artivion make?

Artivion (NYSE:AORT) has a market capitalization of $624.24 million and generates $313.79 million in revenue each year. The company earns $-19,190,000.00 in net income (profit) each year or ($0.73) on an earnings per share basis.

How many employees does Artivion have?

The company employs 1,300 workers across the globe.

How can I contact Artivion?

Artivion's mailing address is 1655 Roberts Blvd NW, Kennesaw, Georgia 30144-3632. The official website for the company is www.cryolife.com. The company can be reached via phone at (770) 419-3355, via email at investors@cryolife.com, or via fax at 770-426-0031.

This page (NYSE:AORT) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -